Skip to main content

Series C Biotechnology Companies

Explore 170 biotechnology startups that raised series c funding. Access verified founder contact information and fundraising data.

Total Companies
170
Total Funding
$1.4B
Avg Funding
$57.4M
Cities
22

Export 170 Series C Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Copenhagen, Denmark
$157.0M
raised

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

Woburn, United States
$39.6M
raised

MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

Munich, Germany
$400.6M
raised

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

Seattle, United States
$30.0M
raised

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

San Diego, United States
$5.4M
raised

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

Sep 2025
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 170 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Zürich, Switzerland
$38.9M
raised

Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.

Sep 2025
Series C

Founder Contacts

41,000+ verified contacts

New York, United States
$44.0M
raised

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Aug 2025
Series C

Founder Contacts

41,000+ verified contacts

Durham, United States
$8.0M
raised

GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.

Jun 2025
Series C

Founder Contacts

41,000+ verified contacts

Lyon, France
$6.9M
raised

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Jun 2025
Series C

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$25.7M
raised

PolyActiva develops products that enable drug release from medical devices.

May 2025
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 170 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Durham, United States
$150.0M
raised

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Apr 2025
Series C

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$31.8M
raised

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Mar 2025
Series C

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$18.2M
raised

Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions

Mar 2025
Series C

Founder Contacts

41,000+ verified contacts

Wadenswil, Switzerland
$54.9M
raised

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Jan 2025
Series C

Founder Contacts

41,000+ verified contacts

Saint Louis, United States
$105.0M
raised

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

Jan 2025
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 170 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Seongnam, South Korea
$13.6M
raised

Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.

Dec 2024
Series C

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$42.0M
raised

Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits

Dec 2024
Series C

Founder Contacts

41,000+ verified contacts

Konstanz, Germany
$15.8M
raised

CarboCode develops sphingolipids that are useful for the operation of the brain, skincare, and the development of babies.

Dec 2024
Series C

Founder Contacts

41,000+ verified contacts

Seongnam, South Korea
$16.6M
raised

Novelty Nobility is a private biotech company focused on the research of novel angiogenesis targets and develop antibody-based therapeutics.

Nov 2024
Series C

Founder Contacts

41,000+ verified contacts

Seattle, United States
$38.0M
raised

Arzeda is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals.

Sep 2024
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 170 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Schlieren, Switzerland
$11.0M
raised

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Sep 2024
Series C

Founder Contacts

41,000+ verified contacts

Osaka, Japan
$1.7M
raised

Luxana Biotech is established to contribute to medical treatment for suffering patients, .

Sep 2024
Series C

Founder Contacts

41,000+ verified contacts

Boston, United States
$112.3M
raised

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Aug 2024
Series C

Founder Contacts

41,000+ verified contacts

Hohen Neuendorf, Germany
$5.5M
raised

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Aug 2024
Series C

Founder Contacts

41,000+ verified contacts

Carmel, United States
$63.5M
raised

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Aug 2024
Series C

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 170 companies

Ready to Connect with Series C Biotechnology Startups?

Get verified founder emails, funding details, and company data for 170 series c biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked